PowerPoint Presentations shared by speakers of the 13th European AIDS Conference powered by - MULTIWEBCAST

13th European AIDS Conference

WELCOME MESSAGE

LIST OF PRESENTATIONS/COURSES

OTHER WEBCASTS

Webcasted Presentations

BROWSE:

ALL PRESENTATIONS/COURSES

SPEAKERS

PPT SLIDES

VIDEO PODCASTS

	Charles Kelly
		Introduction 2011-10-12 - English

	Charles Lacey
		Overview of New Advances and Latest Results from the Biomedical Prevention Research Field 2011-10-12 - English

	Michael Rayment
		HIV Testing and Late Diagnosis: 2 Clinical Cases 2011-10-12 - English

	Iain Reeves
		HIV Testing and Late Diagnosis: Mini Lecture: HIV Testing and Late Diagnosis 2011-10-12 - English

Understand definitions of late presentation. Understand the importance of late presentation. Have knowledge of strategies to improve testing for HIV. Understand barriers to HIV testing.

	Muge Cevik
		When to Start and What With?: 2 Clinical Cases 2011-10-12 - English

	Calvin Cohen
		When to Start and What With?: Mini Lecture: When to Start and What With? 2011-10-12 - English

To understand the controversy about when HIV treatment should be started. To review the preferred alternatives for starting therapy and why they are listed as such. To discuss some alternatives to these preferred regimens.

	Simon Shaw
		Antiretroviral Toxicity & Management: Case 1 2011-10-12 - English

	Christiana Noestlinger
		Latest Findings and Research Gaps in the Social Science of HIV Prevention 2011-10-12 - English

	François Berdougo
		Good Practices of Community Involvement in Ongoing Biomedical Prevention Research Initiatives - Examples from France 2011-10-12 - English

	Gus Cairns
		Community Involvement in the Planned UK Pilot Proposal for Intensive Combination Prevention for Gay Men in England 2011-10-12 - English

	Simon Shaw
		Antiretroviral Toxicity & Management: Case 2 2011-10-12 - English

	Nneka Nwokolo
		Pregnancy & Women\'s Issues: Mini Lecture: Pregnancy & Women\'s Issues 2011-10-12 - English

	Miriam Samuel
		Pregnancy & Women\'s Issues: 2 Clinical Cases 2011-10-12 - English

	Andrea Calcagno
		TB, Poly-Pharmacy & Drug Interactions: 2 Clinical Cases 2011-10-12 - English

	Giovanni Di Perri
		TB, Poly-Pharmacy & Drug Interactions: Mini Lecture: TB, Poly-Pharmacy & Drug Interactions 2011-10-12 - English

	Emma Page
		Hepatitis Co-Infection: 2 Clinical Cases 2011-10-12 - English

	Sanjay Baghani
		Hepatitis Co-Infection 2011-10-12 - English

	Djordje Jevtovic
		Introductory Remarks 'HIV in Serbia' 2011-10-12 - English

	Nenad Petkovic
		HIV and Human Rights 2011-10-12 - English

	Sir Roy Anderson
		Estimating the HIV Epidemic in Europe 2011-10-12 - English

	Josip Begovac
		Barriers and Needs for Optimal HIV Care 2011-10-12 - English

	Kenneth Mayer
		PREP: Ready for Implementation? 2011-10-13 - English

1. to discuss the rationale for the use of antiretroviral drugs for prevention 2. to discuss the current implementation issues involved in the use of antiretroviral drugs for prevention

	Vincent Soriano
		Dolutegravir (DTG, S/GSK1349572) Treatment of Subjects with Raltegravir (RAL) Resistance: Viral Suppression at Week 24 in the VIKING Study 2011-10-13 - English

	Nathan Clumeck
		The Lubumbashi Trial: Week 48 Data: Comparison between Lopinavir/r (LPV/r) versus Nevirapine (NVP)-based Regimens in Treatment-na? Patients in a Developing Country 2011-10-13 - English

	Gilles Wandeler
		Tenofovir in Second-line Antiretroviral Therapy in Southern Africa: Collaborative Analysis of Cohort Studies 2011-10-13 - English

	Stefano Rusconi
		Maraviroc (MVC) as Intensification Strategy in Immunological Non-responder HIV-infected Patients with Virologic Success on HAART 2011-10-13 - English

	Alessandra Viganò
		Mini Lecture: Non-AIDS Comorbidity in Children 2011-10-13 - English

	M. Parczewski
		IL28B Gene Polymorphisms and All-cause Mortality in HIV Infected Patients 2011-10-13 - English

	Alan Winston
		Factors Influencing Neurocognitive Function in a Large Cohort of HIV Infected Patients on Effective Antiretroviral Therapy 2011-10-13 - English

	Paola Cicconi
		Correlates of Early Menopause in HIV-infected Women (DIDI Study) 2011-10-13 - English

	Mong Tran
		AIDS Lipodystrophy and Anti-proteases: Molecular Homology of HIV-1 Gag Proteolytic Site with Adipokinetic Hormone (ADH) 2011-10-13 - English to be announced!

	Jens Lundgren
		Mini Lecture: EACS Co-morbidity Guidelines Update 2011-10-13 - English

	Yazdan Yazdanpanah
		Mini Lecture: The Challenge of Sustaining the Success of ART in Resource Limited Countries 2011-10-13 - English

	Brian West
		Stockouts Overview 2011-10-13 - English

	Anna Koshikova
		Stockouts in Ukraine: Patient/Community Groups Perspective 2011-10-13 - English

	David Hans-Ulrich Haerry
		Switching Strategies for Patients - What to Do when Stockouts Occur 2011-10-13 - English

	MOHAMMED LAMORDE
		Steady-state Exposure of Ritonavir Is Reduced by a High Fat Meal in Ugandan Patients Receiving Lopinavir Plus Ritonavir Co-formulated Tablets 2011-10-13 - English

	Manoli Vourvahis
		Impact of Genetic Variants of OATP1B1 (SLCO1B1) on Maraviroc Pharmacokinetics 2011-10-13 - English

	Maria Nikolova Stoimenova
		HIV-specific CD8 T Cells Are Resistant to Treg-mediated Modulation of PD1/PD-L1 Expression 2011-10-13 - English

	Grigory Kaminskiy
		CD4+ T-lymphocyte Loss in HIV-infected Women in Respect to Pregnancy 2011-10-13 - English

When we should not stop HAART after delivery if HAART was prescribed to prevent mother to child transmission.

	Saye Khoo
		Mini Lecture: Treating HIV & Comorbidity: Drug Interactions 2011-10-13 - English

	Muge Cevik
		Tenofovir (TFV) Pharmacokinetics (PK) in HIV Infected Individuals over 40 Years of Age 2011-10-13 - English

	Giovanni Di Perri
		Pharmacokinetics and Pharmacodynamics of Etravirine 400mg Once Daily in Treatment Na? Patients 2011-10-13 - English

	Laura Waters
		Pharmacokinetics (PK), Efficacy and Safety of Switching from Efavirenz (EFV) to Maraviroc (MVC) Twice-daily (BID) in Patients Suppressed on an EFV-containing Regimen as Initial Therapy 2011-10-13 - English

	Agostino Riva
		Effective Translation from Pharmacogenomics to Clinical Practice UDP-glucuronosyltransferase and Atazanavir 2011-10-13 - English

	Maren Blonk
		The Influence of Ginkgo Biloba on the Pharmacokinetics of the HIV Integrase Inhibitor Raltegravir 2011-10-13 - English

	Aseel Hegazi
		Raltegravir in the Prevention of Mother to Child Transmission of HIV: Effective Transplacental Transfer and Delayed Plasma Clearance Observed in Pre-term Neonates 2011-10-13 - English

	Sharon Lewin
		Overview of Scientific Advances Toward an HIV Cure 2011-10-13 - English

Understand the main barriers to cure of HIV Understand how and where HIV latency is established Understand the concepts of sterilising and functional cure Understand the rationale as well as the pros and cons of current clinical trials aimed at activating latent HIV and the use of gene therapy

	Christine Rouzioux
		What are the Best Tools to Detect HIV Persistence? 2011-10-13 - English

	Nikos Dedes
		The Patient\'s Perspective Regarding Studies of HIV Cure 2011-10-13 - English

	Teresa Branco
		Mini Lecture: East Meets West: Management of Women Living with HIV 2011-10-13 - English

	Fiona Lyons
		Case 1: Managing Complications in Pregnancy 2011-10-13 - English

	Cristiana Anca Oprea
		Mother to Child Transmission of HIV Infection: A Comparative Analysis between Mothers with Parenteral versus Sexual Mode of HIV Transmission 2011-10-13 - English

	Luminita Ene
		Patterns of HIV-associated Neurocognitive Disorders in a Cohort of Young Adults with Parenterally-aquired HIV-infection during Childhood 2011-10-13 - English

	José Gatell
		Starting Antiretroviral Therapy in 2011 2011-10-14 - English

	Konstantinos Protopapas
		The Epidemiology of HPV Anal Infection in a Cohort of HIV Patients 2011-10-14 - English

The epidemiology of HPV anal infection in a cohort of HIV patients Objectives. To investigate anal HPV infection in HIV infected patients and correlate cytological findings with molecular findings, clinical data and immunological parameters. Methods: Prospective...(more)

	Vincent Soriano
		Hepatitis Delta in HIV-infected Individuals in Europe 2011-10-14 - English

	Dorota Bander
		JC Virus DNA Detection in Cerebrospinal Fluid of Patients with Neuro-AIDS - Retrospective Analysis from Single Centre in Poland 2011-10-14 - English

	Edmund Ong
		HIV Testing: How Are We Doing? Results of British HIV Association (BHIVA) National Audit 2010. On the behalf of BHIVA Audit and Standards Sub-committee 2011-10-14 - English

	Alessia Mammone
		Estimating the Number of Undiagnosed People with HIV Infection in Lazio, Italy, Using Surveillance Data 2011-10-14 - English

	Dominique Costagliola
		Impact of Delayed Access to Care (with AIDS or CD4< 350/mm3) on the Risk of Death in HIV-infected People in France (2003-2009) 2011-10-14 - English

	Brian Gazzard
		Mini Lecture: HIV In Europe Initiative: What is Next? 2011-10-14 - English

	Massimo Puoti
		Mini Lecture: Monitoring & Managing Hepatitis B in Those with HIV 2011-10-14 - English

Apply monitoring and treatment strategies for HIV/HBV coinfected patients in their practice.

	Nicolas Merchante Gutierrez
		Liver stiffness correlates with Child-Turcotte-Pugh and MELD scores and predicts Clinical Outcome in HIV/HCV-coinfected Patients with Compensated Liver Cirrhosis 2011-10-14 - English

	Massimiliano Fabbiani
		Predictors of Worsening Liver Fibrosis Evaluated through FIB-4 in HIV-HCV Co-infected Patients Starting Combined Antiretroviral Therapy (cART) 2011-10-14 - English

	Karin Neukam
		Methadone Maintenance Therapy Does Not Influence on the Outcome of Chronic Hepatitis C Treatment with Pegylated Interferon and Ribavirin 2011-10-14 - English

	Manuela Colafigli
		Natural Variation of the NS3 Region in HCV Genotype 1 Patients with or without HIV-1 Infection: Prevalence and Predictors of Resistance Mutations to HCV NS3-protease Inhibitors and Other Substitutions 2011-10-14 - English

	Lars Peters
		Chronic Hepatitis C (HCV) Infection and Chronic Kidney Disease (CKD) in HIV-infected Patients in the EuroSIDA Study 2011-10-14 - English

	Daniel Grint
		Predictors of Hepatitis C RNA Levels in HIV Co-infected Individuals in a Prospective Cohort Study 2011-10-14 - English

	Nathan Clumeck
		EACS HIV Treatment Guidelines "What's New" 2011-10-14 - English

	Jens Lundgren
		EACS HIV Treatment guidelines :What’s new for co-morbidity ? 2011-10-14 - English

	Martina Hennessy
		Mini Lecture: Medical Management of Drug Dependency in Those with HIV 2011-10-14 - English

	Luigia Elzi
		Choice of Initial Combination Antiretroviral Therapy Regimen in Treatment-naive HIV-infected Individuals 2011-10-14 - English

	Jose Arribas
		Interleukin-6 and C-reactive Protein Levels after 144 Weeks of Efficacy of Darunavir / Ritonavir Monotherapy versus DRV/r + 2NRTIs in the MONET Trial for Patients with HIV RNA < 50 Copies/mL at Baseline 2011-10-14 - English

	Kanitta Bundhamcharoen
		Burdenof HIV/AIDS in Thailand: A Consequence of Antiretroviral Therapy 2011-10-14 - English

	Eoin Feeney
		In Antiretroviral-na? Subjects, Six Months of Dual Protease Inhibitor Therapy Improves Subcutaneous Adipose Tissue Mitochondrial Function without Affecting Adipogenic Gene Expression - The HIVNAT019 Study 2011-10-14 - English

	Calvin Cohen
		Switching from Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Single Tablet Regimen (STR) to Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) STR in Virologically Suppressed, HIV-1 Infected Subjects 2011-10-14 - English

	Vincent Calvez
		Mini Lecture: Resistant Minority Variants: Clinical Implications 2011-10-14 - English

	Miriam Lichtner
		Study of Dendritic Cell Recovery and Immune Activation in Patients Treated with Dual Regimen Containing Protease Inhibitors Plus Raltegravir 2011-10-14 - English

	Julie Gaardbo
		Regulatory T Cells (Tregs) Are Extremely Prevalent in HIV-infected Individuals with Immunological Non-response 2011-10-14 - English

	Michael Miller
		Low Rates of Integrase Resistance for Elvitegravir and Raltegravir at Week 48 in the Phase 3 Clinical Study GS-US-183-0145 2011-10-14 - English

	Marye Hofstra
		Low-level Viremia and Blips Are Preceded by Positive HIV-1 Viral Load Results below the Currently Used Clinical Cut-off 2011-10-14 - English to be announced!

	Isabelle Abbate
		Detection and Characterization of CXCR4-using Variants in Gut and Peripheral Blood of Early Infected HIV Patients by Ultra-sensitive Next Generation Sequencing 2011-10-14 - English

	Caroline Sabin
		Mini Lecture: EuroCoord, Bringing European Cohort Studies and Collaborations on HIV Together 2011-10-14 - English

	Joanne Reekie
		The Incidence of Serious Non-AIDS Defining Infections in the EuroSIDA Cohort 2011-10-14 - English

	Carlo - Federico Perno
		High Pre-therapy Viral Load Is Associated with Delayed and Decreased Control of HIV Replication also at the Time of Modern HAART 2011-10-14 - English

	Richard Price
		Epidemiology and Pathogenesis of HAND in 2011 2011-10-15 - English

	Paola Cinque
		Therapeutic Approaches to HAND in 2011 2011-10-15 - English

	Nathan Clumeck
		Closing and Introduction of 14th European AIDS Conference 2013 2011-10-15 - English

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™